NUVB
Nuvation Bio Inc
5.70$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.5% | -1.3% | -3.0% | -3.9% | -5.4% | -8.9% | +31.4% | -7.1% | -1.1% | +2.6% | +22.0% | |
| – | -1.4% | -1.4% | -3.4% | -3.8% | -6.9% | -9.6% | +31.0% | -7.3% | -1.0% | +3.5% | +22.8% | |
| – | +74.8% | -19.1% | -0.7% | -12.4% | +18.9% | +34.3% | +416.9% | -60.1% | +65.9% | -23.6% | +106.2% | |
| – | -1.3% | -2.3% | -3.3% | -4.9% | -8.5% | -8.2% | +31.6% | -9.7% | -3.6% | +0.9% | +23.8% | |
| – | +22.1% | +15.7% | -6.3% | +6.0% | +283.2% | -66.5% | +22.2% | +107.4% | +39.8% | +34.2% | +22.1% | |
| – | – | – | – | – | – | – | +3,842.9% | +934.4% | +99.8% | +38.8% | +25.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -5.2% | +66.3% | -4.6% | +175.4% | -3.8% | -4.0% | -4.1% | -4.3% | |
| – | -15.1% | +16.6% | +1,669.1% | -79.6% | +11.6% | -5.0% | +275.6% | +0.5% | +4.9% | +0.5% | +68.8% | |
| – | -13.4% | +12.8% | +224.2% | +15.5% | -1.3% | -9.4% | +25.7% | +2.7% | +20.7% | -3.3% | +9.1% | |
| – | +3.0% | +2.6% | +577.7% | -25.6% | -22.2% | -4.7% | -2.4% | +1.3% | +1.5% | +0.3% | -0.3% | |
| – | -6.9% | +10.3% | +113.9% | +137.6% | -48.7% | +66.0% | +112.8% | -31.5% | -38.3% | +136.7% | -46.1% | |
| – | – | – | – | – | – | – | – | +0.2% | +0.3% | +0.3% | +412.7% | |
| – | -1.1% | -1.8% | -56.7% | +95.5% | -7.7% | -9.6% | -11.1% | -12.6% | -6.2% | +4.5% | -20.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.1% | +11.7% | +11.8% | +23.2% | +0.5% | +0.6% | +0.5% | +0.6% | +9.6% | -7.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.